SBBP Strongbridge Biopharma

Strongbridge Biopharma Plc is a biopharmaceutical company which focuses on the development, in-licensing, acquisition, and commercialization of various complementary products and product candidates that target rare diseases.

As of 06/11/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Ireland
IPO date:  10/16/2015
Outstanding shares:  67,588,878
Average volume:  2,313,820
Market cap:   $192,628,302
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G85347105
ISIN:        IE00BYZ5XL97
Sedol:      BYZ5XL9
Valuation   (See tab for details)
PE ratio:   -4.36
PB ratio:   3.45
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy